Drug Approval | August 16, 2021
Zydus Cadila receives final approval for Mesalamine extended-release capsules
The group has a total of 320 ANDA approvals
The group has a total of 320 ANDA approvals
This is the first of its kind vaccine for Covid 19 to get the go-ahead
It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
It’s an AB-rated generic therapeutic version of Durezol
The company is eligible for 12 months exclusivity from launch
The approval is based on a multi-centre, single-arm, open-label pivotal clinical trial
TSC causes epilepsy in up to 85 % of patients, and up to 60 % of those patients do not respond to standard anti-seizure medicines
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
The group now has 320 approvals and has so far filed over 400 ANDAs
Subscribe To Our Newsletter & Stay Updated
